Form 4: Integra LifeSciences Director Barbara Hill Reports Changes in Beneficial Ownership
SEC Form 4 Filing
Director Barbara Hill reports acquisition of Integra LifeSciences Holdings Corp shares through previously awarded stock.
Summary
- On May 9, 2025, Barbara Hill, a director of Integra LifeSciences Holdings Corp, reported changes in beneficial ownership of the company's common stock.
- Hill acquired 6,939 shares and 19,592 shares of common stock, both at a price of $0.
- Following these transactions, Hill directly owns 126,853 shares and indirectly owns 36,350 shares through a trust.
Sentiment
Score: 5
Explanation: This is a routine filing, indicating standard insider activity. It doesn't inherently suggest positive or negative sentiment.
Industry Context
Form 4 filings are standard practice for company insiders to report transactions in their company's stock, providing transparency to investors.
Key Dates
| Date | Description |
|---|---|
| 05/09/2025 | Date of the reported transactions (stock acquisitions). |
| 05/13/2025 | Date of signature for the Power of Attorney. |
Keywords
Form 4, Beneficial Ownership, Director, IART, Integra LifeSciences, Barbara Hill, Stock Acquisition
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.